ALLIANCES, PARTNERSHIPS & LICENSING OF CLINICAL-PROVEN DRUGS
EXECUTING A VIABLE FINANCING STRATEGY TO FUND R&D PROJECTS
IP WITH MULTIPLE MONETIZATION OPTIONS AFTER REACHING CLINICAL STATUS
One of our principles in developing business is to partner our innovative products during late preclinical to early proof-of-concept clinical stages. To reach our objective, we have implemented a well-defined strategy that guides the identification of potential partnerships to support our product pipeline.
Strong partnerships have the power to spark innovation that one organization could not create on its own. At World Pharmatech, we are always looking for new ways of working with academic or industry researchers who share our passion for advancing science and helping with innovative solutions.
The integration of our in-house and collaborative R&D capabilities has contributed significantly to the cancer research field and achieved major milestones during the last 10 years. We actively seek for scientific breakthroughs by tapping into the world’s greatest minds through close collaboration with renowned academic institutions.